期刊
GENE
卷 330, 期 -, 页码 133-142出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.gene.2004.01.014
关键词
hKLF5; promoter; gene expression; cancer cell line
资金
- NCI NIH HHS [CA87921] Funding Source: Medline
Human Kruppel-like factor 5 (hKLF5) is a transcription factor with a potential tumor suppressor function in prostate and breast cancers. In the majority of cancer samples examined, a significant loss of expression for KLF5 has been detected. Whereas hemizygous deletion appears to be responsible for KLF5's reduced expression in about half of the cases, the mechanism for reduction is unknown in the remaining half, gene promoter methylation does not appear to be involved. In this report, we studied the regulation of KLF5 and cloned and functionally characterized a 1944-bp fragment of the 5'-flanking region of the hKLF5 gene. Several initogens as well as global demethylation induced the expression of KLF5. implicating multiple factors in the regulation of KLF5. KLF5's promoter lacks a TATA box and has a GC-rich region. Deletion mapping in combination with promoter activity assay showed that multiple cis-elements are involved in the transcriptional regulation of KLF5, some of which may play a repressor role whereas some others play an enhancer role. The Sp1 site between position - 239 and - 2 19 is essential for a basal promoter activity. Deletion or mutations of this Sp 1 site significantly reduced promoter activity in several epithelial cell lines. Electrophoretic mobility shift assays (EMSAs) revealed that the Sp 1 site binds Sp 1 protein in nucleic extracts of different cell lines. In addition. overexpression of Sp 1 protein transactivates KLF5 promoter activity. These findings suggest that Sp 1 is a key transcription factor in KLF5's dynamic transcriptional regulation. (C) 2004 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据